Company Profiles

driven by the PitchBook Platform

Tioga Pharmaceuticals

Description

Developer of therapies for the treatment of gastrointestinal diseases. The company's asimadoline is an orally administered small molecule therapeutic for the treatment of irritable bowel syndrome and functional dyspepsia.

2005

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$10M

Latest Deal Amount

$52M

Total Amount Raised

Description

Developer of therapies for the treatment of gastrointestinal diseases. The company's asimadoline is an orally administered small molecule therapeutic for the treatment of irritable bowel syndrome and functional dyspepsia.

Website:

www.tiogapharma.com

Formerly Known As

Icon Pharmaceuticals

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

4747 Executive Drive Suite 700 San Diego, CA 92121United States +1 (858) 677-6077
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Tioga Pharmaceuticals's full profile, request a free trial.

Tioga Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Tioga Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Tioga Pharmaceuticals Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BB BiotechVenture CapitalMinority000 0000000 0000
Forward VenturesVenture CapitalMinority000 0000000 0000
Genesys CapitalVenture CapitalMinority000 0000000 0000
New Leaf Venture PartnersVenture CapitalMinority000 0000000 0000
Thomas McNerney & PartnersVenture CapitalMinority000 0000000 0000
BB Biotech Venture Capital
Forward Ventures Venture Capital
Genesys Capital Venture Capital
New Leaf Venture Partners Venture Capital
Thomas McNerney & Partners Venture Capital

Tioga Pharmaceuticals Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Stuart Collinson Ph.DFounder, Chief Executive Officer & Chairman
Sophie Visonneau Ph.DChief Operating Officer
Kathie Bishop Ph.DChief Scientific Officer
Dawn McGuire MDChief Medical Officer
Stuart Collinson Ph.D Founder, Chief Executive Officer & Chairman
Sophie Visonneau Ph.D Chief Operating Officer
Kathie Bishop Ph.D Chief Scientific Officer
Dawn McGuire MD Chief Medical Officer

Tioga Pharmaceuticals Board Members (4)

NameRepresentingRoleSinceContact
Info
Arno Hartmann Ph.DSelfBoard Member000 0000
James Niedel Ph.DNew Leaf Venture PartnersCo-Founder & Venture Partner000 0000
Jason Brown Ph.DThomas McNerney & PartnersPrincipal000 0000
Stuart Collinson Ph.DTioga PharmaceuticalsFounder, Chief Executive Officer & Chairman000 0000
Arno Hartmann Ph.D Board Member Self
James Niedel Ph.D Co-Founder & Venture Partner New Leaf Venture Partners
Jason Brown Ph.D Principal Thomas McNerney & Partners
Stuart Collinson Ph.D Founder, Chief Executive Officer & Chairman Tioga Pharmaceuticals
Request full access to PitchBook